STOCK TITAN

Carta Healthcare names Brent Dover CEO

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Carta Healthcare (Private) announces the appointment of Brent Dover as CEO, triples revenue, and secures a series B funding round of $25 million. The company also received the Health Care of the Future Innovation Award in 2023.
Positive
  • Tripled revenue in 2023
  • Expanded healthcare system customers by 50%
  • Received $25 million in series B funding
  • Received Health Care of the Future Innovation Award in 2023
Negative
  • None.

Carta Healthcare closes series B, triples revenue, and brings in seasoned health tech leader Brent Dover to accelerate growth

SAN FRANCISCO--(BUSINESS WIRE)-- Health tech company Carta Healthcare®, whose mission is to harness the value of clinical data, is pleased to announce the appointment of Brent Dover as chief executive officer. Dover succeeds former CEO Matt Hollingsworth who co-founded Carta Healthcare in 2017 and who remains a member of the board. In his new role, he will continue to focus on product innovation, business development, and strategic partnerships for Carta Healthcare’s market-leading solutions.

“I am thrilled to welcome Brent to the Carta Healthcare leadership team. While his expertise in scaling health tech companies is impressive, what stands out most is Brent's authentic dedication to our mission and his confidence in what we will be able to achieve together,” said Hollingsworth.

Dover brings to Carta Healthcare a wealth of leadership experience in emerging companies with a focus on data-driven healthcare solutions. Over the past two decades, Dover was instrumental in leading several companies through rapid growth trajectories, joining each at pivotal growth stages. Dover most recently served as CEO at Kalderos (2022-2023), CEO at Commure (2019-2021), which in 2021 reached a $3.5 billion valuation, president of Health Catalyst (2013-2018), now a publicly traded healthcare analytics company (NASDAQ:HCAT), and president of Medicity (2007-2012), which sold to Aetna in 2011.

"I am thrilled to join Matt at this critical juncture of Carta Healthcare’s journey. From the very first encounter with the team, their unwavering passion for assisting healthcare professionals and harnessing the power of real-time clinical data left an indelible impression on me. They have built an impressive company, and their strategy is working," said Dover.

2023 has been a year of substantial growth for Carta Healthcare, achieving a threefold increase in revenue while expanding its healthcare system customers by 50%. In addition to its rapid expansion this year, Carta Healthcare expanded its product offerings and enjoyed its fourth consecutive year of 100% customer retention. The $25 million series B funding round in March of 2023 was used in part to scale operations, enhance and expand the company's products, hire key team members necessary for the company's growth, and strengthen the company's technological infrastructure. This October, Carta Healthcare received the Health Care of the Future Innovation Award from the Portland Business Journal.

About Carta Healthcare:

Carta Healthcare was founded in 2017 by a team dedicated to creating a healthier future by advancing the technology surrounding data practices. Today, Carta Healthcare is a leader in delivering improved data gathering solutions to healthcare systems related to a patient's diagnosis, treatment, and outcomes. Carta Healthcare’s solutions have revolutionized the processes surrounding registry databases, resulting in markedly faster data collection, superior quality of data, and considerable cost savings for healthcare providers.

More information can be found at www.carta.healthcare

Grace Gervais

PRforCarta@bospar.com

Source: Carta Healthcare

FAQ

Who is the new CEO of Carta Healthcare?

Brent Dover has been appointed as the new CEO of Carta Healthcare.

What was the revenue growth for Carta Healthcare in 2023?

Carta Healthcare saw a threefold increase in revenue in 2023.

How much funding did Carta Healthcare secure in its series B round?

Carta Healthcare secured a $25 million series B funding round.

What award did Carta Healthcare receive in 2023?

Carta Healthcare received the Health Care of the Future Innovation Award from the Portland Business Journal.

Health Catalyst, Inc

NASDAQ:HCAT

HCAT Rankings

HCAT Latest News

HCAT Stock Data

382.54M
52.54M
3.51%
88.84%
2.59%
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link
United States of America
SOUTH JORDAN

About HCAT

health catalyst is dedicated to enabling health care organizations to fundamentally improve care by building the most comprehensive and fully integrated suite of healthcare data warehousing and process improvement solutions available. health catalyst was formed by a group of healthcare veterans with vast data warehousing and quality improvement experience. our founders and executives collaborated for nearly a decade to revolutionize clinical process models using analytics. during development, they faced numerous hurdles in the quest to develop a data warehouse that could handle the complexities unique to healthcare data. after determining that the predominant approaches to data modeling weren’t effective for healthcare data, they discovered the solution, which is now known as the adaptive data architecture. using a late-binding bus architecture, catalyst’s adaptive data model is agile, flexible, and can be implemented in a matter of weeks compared to the months or years traditional app